Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Life length

Explore full profile

Offers a series of tests to measure cellular senescence, a crucial biological marker to establish biological age, for the early detection of chronic diseases and for risk stratification

Madrid, SpainFounded 2010Biotech & Life Sciences
Valuation $25–50M Last recorded · 2023
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Life length and the history behind them.

About Life length

Life Length is a pioneering biotechnology company that specializes in advanced telomere length and biological age testing. Telomeres are protective caps at the ends of chromosomes, and their length can indicate cellular aging and overall health. Life Length operates in the healthcare and biotechnology markets, providing services to a diverse range of clients including large corporations, small and medium-sized enterprises (SMEs), healthcare organizations, research institutions, and individual consumers.

The company is highly accredited, being the only Spanish laboratory with U.S. Federal accreditation. This positions Life Length as a trusted provider of clinical analysis services. Since the onset of the COVID-19 pandemic, Life Length has expanded its offerings to include a variety of COVID-19 diagnostic tests. These include PCR tests, which detect the presence of the virus, and ELISA tests, which measure the levels of different antibodies (IgA, IgM, IgG) in response to the virus. These services are available to both organizations and individuals, helping to ensure public health and safety.

Life Length's business model revolves around offering specialized diagnostic tests and research services. The company generates revenue by providing these tests on a contract basis to its diverse clientele. This includes not only COVID-19 testing but also telomere length analysis and other preventive medicine services. By catering to both the healthcare sector and individual consumers, Life Length has established a robust and versatile revenue stream.

In summary, Life Length is a leader in telomere and biological age testing, with a strong foothold in COVID-19 diagnostics. The company serves a wide range of clients and operates on a contract-based business model, ensuring steady revenue through its specialized services.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2010
Headquarters
Madrid, Spain
Employees
39
Open positions
None listed
Dealroom signal
61.7/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Testing, Biotechnology, Biomarkers, Spinout, Go Global (EIT Health), Go Global 2018 (EIT Health), Biotech and Pharma
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Oct 2023 $4.4M $37M Undisclosed ↗
GRANT✓Other financing Oct 2020 $0 — Undisclosed —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Life length website traffic

Latest recorded traffic for Life length is 2.8K monthly website visits, up 33.3% over the last three months. Life length's team declined 15.2% over the past year.

Latest monthly visits2.8K 3-month web change+33.3% 1-year team growth-15.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Mind the Gap
  • European Innovation Council

Other known investors3 additional known investors

  • CNIO
  • EIT Health
  • Fundación Parque Científico de Madrid
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇪🇸 Spain92.6%
🇬🇧 United Kingdom3.7%
🇨🇿 Czech Republic3.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Life length on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Life length’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.